Fresh Tracks Therapeutics Overview

Fresh Tracks Therapeutics Operating Income

Operating Income for FRTX.

Quarterly Operating Income

$-1652000.00

↓ 64.03% YoY

As of Dec 31, 2023

Annual Operating Income (TTM)

$-6360000.00

↓ 70.47% YoY

Trailing 12 months ending Dec 31, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin